| Name | (3R)-1'-Benzyl-3-phenyl-3,4'-bipiperidine-2,6-dione |
|---|
| Description | Levetimide is a potent and stereoselective inhibitor of [3H](+)pentazocine binding, with a Ki of 2.2 nM[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Levetimide potently inhibits [3H]DTG binding although without stereoselectivity (Ki value of 103 nM) [1]. |
| References |
| Density | 1.178g/cm3 |
|---|---|
| Boiling Point | 543.9ºC at 760mmHg |
| Molecular Formula | C23H26N2O2 |
| Molecular Weight | 362.46500 |
| Flash Point | 282.7ºC |
| Exact Mass | 362.19900 |
| PSA | 52.90000 |
| LogP | 3.48700 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| HS Code | 2933399090 |
|---|
|
~%
21888-99-3 |
| Literature: JANSSEN PHARMACEUTICA N.V. Patent: WO2007/90826 A1, 2007 ; Location in patent: Page/Page column 65 ; WO 2007/090826 A1 |
| HS Code | 2933399090 |
|---|---|
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |